Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 27

    1.

    Changes in the Use of HIV Antiretroviral Resistance Testing in a Large Cohort of U.S. Patients, 1999 to 2006.

    Buchacz K, Baker RK, Young B, Brooks JT; the HIV Outpatient Study (HOPS) Investigators.

    J Acquir Immune Defic Syndr. 2009 Oct 16. [Epub ahead of print]PMID: 19841587 [PubMed - as supplied by publisher]Related articles

    2.

    Trends in Hepatitis C Virus Infection Among Patients in the HIV Outpatient Study, 1996-2007.

    Spradling PR, Richardson JT, Buchacz K, Moorman AC, Finelli L, Bell BP, Brooks JT; the HIV Outpatient Study Investigators1.

    J Acquir Immune Defic Syndr. 2009 Sep 4. [Epub ahead of print]PMID: 19738485 [PubMed - as supplied by publisher]Related articles

    3.

    The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study.

    Palella FJ Jr, Armon C, Buchacz K, Cole SR, Chmiel JS, Novak RM, Wood K, Moorman AC, Brooks JT; HOPS (HIV Outpatient Study) Investigators.

    Ann Intern Med. 2009 Jul 21;151(2):73-84.PMID: 19620160 [PubMed - indexed for MEDLINE]Related articles

    4.

    Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study.

    Young B, Buchacz K, Moorman A, Wood KC, Brooks JT; HIV Outpatient Study (HOPS) Investigators.

    AIDS Patient Care STDS. 2009 Aug;23(8):589-92.PMID: 19591609 [PubMed - in process]Related articles

    5.

    Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure.

    Uy J, Armon C, Buchacz K, Wood K, Brooks JT; HOPS Investigators.

    J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):450-3.PMID: 19474757 [PubMed - indexed for MEDLINE]Related articles

    6.

    Hematologic changes associated with Zidovudine following single-drug substitution from stavudine in a home-based AIDS care program in rural Uganda.

    Forna F, Moore D, Mermin J, Brooks JT, Were W, Buchacz K, Campbell JD, Downing R, Borkowf CB, Weidle PJ.

    J Int Assoc Physicians AIDS Care (Chic Ill). 2009 Mar-Apr;8(2):128-38. Epub 2009 Mar 6.PMID: 19270152 [PubMed - indexed for MEDLINE]Related articles

    7.

    Changes in the Clinical Epidemiology of HIV Infection in the United States: Implications for the Clinician.

    Buchacz K, Rangel M, Blacher R, Brooks JT.

    Curr Infect Dis Rep. 2009 Jan;11(1):75-83.PMID: 19094828 [PubMed - in process]Related articles

    8.

    Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural Uganda.

    Weidle PJ, Moore D, Mermin J, Buchacz K, Were W, Downing R, Kigozi A, Ndazima V, Peters P, Brooks JT.

    AIDS Patient Care STDS. 2008 Oct;22(10):787-95.PMID: 18778241 [PubMed - indexed for MEDLINE]Related articles

    9.

    Antiretroviral therapy improves renal function among HIV-infected Ugandans.

    Peters PJ, Moore DM, Mermin J, Brooks JT, Downing R, Were W, Kigozi A, Buchacz K, Weidle PJ.

    Kidney Int. 2008 Oct;74(7):925-9. Epub 2008 Jul 9.PMID: 18614998 [PubMed - indexed for MEDLINE]Related articles

    10.

    Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.

    Buchacz K, Baker RK, Moorman AC, Richardson JT, Wood KC, Holmberg SD, Brooks JT; HIV Outpatient Study (HOPS) Investigators.

    AIDS. 2008 Jul 11;22(11):1345-54.PMID: 18580614 [PubMed - indexed for MEDLINE]Related articles

    11.

    Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.

    Buchacz K, Weidle PJ, Moore D, Were W, Mermin J, Downing R, Kigozi A, Borkowf CB, Ndazima V, Brooks JT.

    J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):304-11.PMID: 18398971 [PubMed - indexed for MEDLINE]Related articles

    12.

    HIV incidence among men diagnosed with early syphilis in Atlanta, San Francisco, and Los Angeles, 2004 to 2005.

    Buchacz K, Klausner JD, Kerndt PR, Shouse RL, Onorato I, McElroy PD, Schwendemann J, Tambe PB, Allen M, Coye F, Kent C, Park MN, Hawkins K, Samoff E, Brooks JT.

    J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):234-40.PMID: 18340654 [PubMed - indexed for MEDLINE]Related articles

    13.

    Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiency.

    Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Moorman AC, Wood KC, Holmberg SD, Brooks JT; HIV Outpatient Study (HOPS) Investigators.

    J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):27-35.PMID: 17971714 [PubMed - indexed for MEDLINE]Related articles

    14.

    Renal Function in Tenofovir-Exposed and Tenofovir-Unexposed Patients Receiving Highly Active Antiretroviral Therapy in the HIV Outpatient Study.

    Young B, Buchacz K, Baker RK, Moorman AC, Wood KC, Chmiel J, Brooks JT, Hiv Outpatient Study Investigators.

    J Int Assoc Physicians AIDS Care (Chic Ill). 2007 Sep;6(3):178-87. Epub 2007 Jun 19.PMID: 17579126 [PubMed - in process]Related articles

    15.

    Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort.

    Buchacz K, Young B, Baker RK, Moorman A, Chmiel JS, Wood KC, Brooks JT.

    J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):626-8. No abstract available. PMID: 17133215 [PubMed - indexed for MEDLINE]Related articles

    16.

    Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda.

    Weidle PJ, Wamai N, Solberg P, Liechty C, Sendagala S, Were W, Mermin J, Buchacz K, Behumbiize P, Ransom RL, Bunnell R.

    Lancet. 2006 Nov 4;368(9547):1587-94.PMID: 17084759 [PubMed - indexed for MEDLINE]Related articles

    17.

    The Pediatric AIDS Severity Score (PASS): a multidimensional AIDS-severity adjustment for pediatric HIV infection.

    Seage GR 3rd, Buchacz K, Weinberg GA, Patel K, McIntosh K, Dankner WM.

    J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):603-10.PMID: 17003692 [PubMed - indexed for MEDLINE]Related articles

    18.

    Simple Pediatric AIDS Severity Score (PASS): a pediatric severity score for resource-limited settings.

    Patel K, Weinberg GA, Buchacz K, McIntosh K, Dankner WM, Seage GR 3rd.

    J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):611-7.PMID: 17003691 [PubMed - indexed for MEDLINE]Related articles

    19.

    Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients.

    Tedaldi EM, Brooks JT, Weidle PJ, Richardson JT, Baker RK, Buchacz K, Moorman AC, Wood KC, Holmberg SD; and The HOPS Investigators.

    J Acquir Immune Defic Syndr. 2006 Sep;43(1):35-41.PMID: 16885779 [PubMed - indexed for MEDLINE]Related articles

    20.

    Syphilis epidemics and human immunodeficiency virus (HIV) incidence among men who have sex with men in the United States: implications for HIV prevention.

    Buchacz K, Greenberg A, Onorato I, Janssen R.

    Sex Transm Dis. 2005 Oct;32(10 Suppl):S73-9. Review.PMID: 16205297 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...